Ullem Scott B. 4

What Happened
Scott B. Ullem, Chief Financial Officer of Edwards Lifesciences (EW), disposed of shares to satisfy tax liabilities related to equity awards. On 2026-05-07 he surrendered 1,373 shares at $83.20 each for $114,234, and on 2026-05-08 he surrendered 1,661 shares at $82.76 each for $137,464 — a combined 3,034 shares and approximately $251,698. This filing reports share withholding to cover taxes (transaction code F), not an open-market buy or voluntary sale for investment purposes.

Key Details

• Filing: SEC Form 4 filed 2026-05-08 (period of report includes 2026-05-07/2026-05-08). Filing appears timely.
• Transactions:
  • 2026-05-07: 1,373 shares @ $83.20 — $114,234 (disposed; code F)
  • 2026-05-08: 1,661 shares @ $82.76 — $137,464 (disposed; code F)
• Total: 3,034 shares surrendered, ~$251,698.
• Shares owned after transaction: not specified in the filing.
• Remarks: Form notes it reflects changes in beneficial ownership only; no 10b5-1 plan or other footnotes were disclosed.

Context
Transaction code F indicates shares were withheld or surrendered to pay exercise costs or tax obligations (a common, administrative step after option exercises or vesting). These withholdings are typically routine and do not necessarily signal a change in the insider’s view of the company.